|
JBJS welcomes reader comments on published articles. Letters to the Editor are reviewed by JBJS editors but are not peer-reviewed. To submit your letter, please follow the "submit a response" link that appears in the content box at the upper right of the full text of the article.
Letters to the Editor to:
-
- Scientific Articles:
Seth S Leopold, Brigham B Redd, Winston J Warme, Paul A Wehrle, Patrick D Pettis, and Susan Shott
- Corticosteroid Compared with Hyaluronic Acid Injections for the Treatment of Osteoarthritis of the Knee: A Prospective, Randomized Trial
J Bone Joint Surg Am 2003; 85: 1197-1203
[Abstract]
[Full text]
[PDF]
|
|
Electronic letters published:
-
Dr. Leopold responds to Dr. Charalambous
- Seth S. Leopold, Brigham B. Redd, Winston J. Warme, Paul A. Wehrle, Patrick D. Pettis, Susan Shott
(20 October 2003)
-
Corticosteroid Compared with Hyaluronic Acid Injections of the Knee
- Charalambos P Charalambous
(15 October 2003)
|
Dr. Leopold responds to Dr. Charalambous |
20 October 2003 |
|
|
Seth S. Leopold, Orthopaedic Surgeon (Hip and Knee Replacement) University of Washington Medical Center, Brigham B. Redd, Winston J. Warme, Paul A. Wehrle, Patrick D. Pettis, Susan Shott
Send letter to journal:
Re: Dr. Leopold responds to Dr. Charalambous
leopold{at}u.washington.edu Seth S. Leopold, et al.
|
Thank you for your letter. You are correct in noting that in our Hylan G-F 20 (Synvisc) group
we aspirated any detectable effusions prior to injecting the
product, while in the corticosteroid group, aspirations were not
performed prior to injection.
As you point out, and as the reference you indicated suggests (1),
the aspiration of joint effusions may produce some relief of
symptoms, and this may indeed have had some impact on our
results.
Our goal was to perform each study intervention as it is commonly
used in practice, and as the manufactuer of the drug/device
directs. The manufacturer's directions (on the package insert) for
Synvisc call for joint aspiration prior to injection, and we felt it was
important to follow this directive carefully. The package insert for
the corticosteroid used in the study does not mandate joint
aspiration, and there is inconsistent performance of joint aspiration
before injection of corticosteroids in the literature, including in the
article you referenced, which apparently aspirated only very large
effusions (ones in which the "bulge sign" or positive patellar tap
was present) (1).
In any case, we used corticosteroid injection as the "control" group,
against which the newer, more expensive product was tested.
There were no consequential differences in efficacy observed
between corticosteroid and Synvisc in our study. Since this
appears to be the case, despite what you -- perhaps correctly --
perceive to be a bias favoring the Synvisc group, this would tend to
support our conclusion: "we do not
consider Hylan G-F 20 a first-line treatment for patients with
osteoarthritis who are considering intra-articular knee injections for
palliation of symptoms."
Thank you again for your interest in our work.
1. Gaffney K, Ledingham J, Perry JD Intra-articular triamcinolone
hexacetonide in knee osteoarthritis: factors influencing the clinical
response. Ann Rheum Dis 1995; 54: 379-381 |
|
Corticosteroid Compared with Hyaluronic Acid Injections of the Knee |
15 October 2003 |
|
|
Charalambos P Charalambous, SPR in Orthopaedics MRCS
Send letter to journal:
Re: Corticosteroid Compared with Hyaluronic Acid Injections of the Knee
bcharalambos{at}hotmail.com Charalambos P Charalambous
|
To the Editor:
I read with
interest the article by Leopold et al. I am writing
regarding the methodology of this study.
The aim of the study was to compare Hylan with steroid injections.
However, the group that received Hyalan also underwent aspiration of
effusions while the group that had steroid injections did not. Aspiration of
effusions alone may influence symptomatology(1). It is thus possible that part
of the response attributed to Hylan may have been due to aspiration of
the effusion.
In the article, no justification was given for not performing aspirations in the steroid group.
Sincerely,
1. Gaffney K, Ledingham J, Perry JD Intra-articular triamcinolone
hexacetonide in knee osteoarthritis: factors influencing the clinical
response. Ann Rheum Dis 1995; 54: 379-381 |
|